SlideShare a Scribd company logo
Theerapan Songnuy M.D.
Jan 3, 2014









Case study
Definition
Epidemiology
Clinical manifestation
Pathogenesis
Diagnosis
Management
Take Home Message


CC: refer
PI: 5d PTA
3 d PTA
4
2 d PTA

10 (
1
2546)
, multiple admissions ( 12
1

56)


PI : (

)

VS: BT 37.5 C,RR 80/min, PR 104/min, BP145/81
Oxygen Sat room air 94% ,
Lungs: Decreased breath sound LLL
CXR : Massive left pleural effusion with tracheal
shift to the right, single soft tissue mass at
right hilar region


PI
14%

CBC: Hb 11 Hct 34 WBC 4140 N 79% L

BUN/Cr : 22/0.5
E’lyte : Na 134 K 4.4 Cl 94 CO2 20
Impression : Left empyema thoracis & right lung
abscess
Refer


PH :
- P1
- P2
- P3
- P4
:
:
G&D:

3 c/s BW 2,600 gm
DFIU GA 36 wk
17-y-old female , healthy
15-y-old female, healthy
10-y-old male, patient

( 10 )
Vaccination:
pneumococcal &

,


PH:
Drug allergy: Nystatin ( urticaria )
Fluconazole ( urticaria )
Ketoconazole ( urticaria)
Food allergy: Cow’s milk, egg, seafood, soy,
wheat accidental exposure
: On BF, Enfa ( flare up of AD,
Nutramigen ( at 9 mon )
Neocate ( 10 mon -3 y)
: Current foods; rice, chicken, pork, fish etc.


PH: Past Infections
- At 2 m of age: Bacterial lymphadenitis
: Common cold q 1 m
: AD treated with Elidel, zyrtec
- At 2 y of age : Bacterial lymphadenitis
- At 4 y of age : Bacterial lymphadenitis
- At 7 y of age : Bacterial lymphadenitis &
multiple abscess at thigh
_ At 4 y
: Serum sIgE to foods ; class 3-4


PH: History of AD treatment
1m
1y
- 5 m PTA
Erythromycin ( 2wk)
Prednisolone (5) 1*3 ( 6 wk)

2

- 2 m PTA


Physical Examination:
- GA: A Thai boy, good consciousness, dyspnea,
no cyanosis
- VS : BT 37 c RR 60/min PR130/min BP 130/80
O2 sat 100% ( via mask with bag 6 L/min)
BW 30 kg ( P50)
- HEENT: mild pale conjunctiva, mild puffy
eyelid with eczema on face, broad nasal base,
no frontal bossing, LN impalpaple
- Lungs : suprasternal & subcostal retraction
decreased breath sound left side


Physical Examination
Heart: normal s1 s2 , no murmur
Abdomen: soft, not tender,
no hepato-splenomegaly
Extremities: no deformities, no edema,
post inflammatory hyperpigmentation
both legs, clubbing of fingers
Skin: Dry, erythematous papule & scaly face , arms
& legs. Paronhychia
Neuro: intact


Problems:
1. Acute dyspnea with decreased
breath sound left lung
2. Recurrent bacterial lymphadenitis
3. Recurrent eczema
4. History of multiple foods allergy
5. History of multiple drugs allergy
6. Mild anemia
7. Mild puffy eye lids
8. Broad nasal base
9. Clubbing of fingers
10. Paronychia


Primary Immunodeficiency diseases
- Hyper IgE syndrome
- CGD
- CVID

Active problems:
- Lung abscess
- Empyema thoracis
- Pleural effusion
DATE

Dec 11,2013

Dec 13, 2013

Dec 16, 2013

RBC

3.53

3.15

3.98

HGB

10.7

9.6

11.5

HCT

32.5

29.1

35.4

MCV

92.1

92.2

92.4

WBC

2990

9280

14770

N ( %)

74.3

51.7

57.4

L ( %)

19.6

28.1

28.3

M (%)

3.0

10.4

12.7

E ( %)

1.1

6.4

0.6

B (%)

0.1

0.1

0.2

Abs NC

2212

4800

8480

Abs LC

586

2610

3740

Platelet

198,000

198,000

389,000

Abs Eo= 594



















WBC
: 12,410
Abs total Lymphocyte : 3,115
Total Lymphocyte (%) :
25.1
Abs CD3
: 2,336
CD3 ( %)
:
75
Abs CD4
: 1,433
CD4 (%)
:
46
Abs CD8
: 748
CD8 (%)
:
24
CD 19(%)
:
23
CD 56(%)
:
2
Hb
Hct
MCV
MCH
MCHC

:
:
:
:
:

11.1
31.7
84.3
29.5
35


CXR
11
56
-BUN/Cr :
- TB/DB :
- ALP
:
- SGOT :
- SGPT :
- ALB
:
- GLOB :
- TP
:
- LDH
:

12/0.4
0.54/0.34
79
34
25
3.5
( 16
( 16
( 16
238

56 = 3.8)
56 = 2.8)
56 = 6.6)


Immunoglobulin level: ( 12
56)
- IgG 815 ( 889- 1359 ) mg/dl
- IgM 72.6 ( 46- 112) mg/dl
- IgA 79
( 71-191)
mg/dl
- Total IgE 28,700 ( < 200) IU/ml
- IgG1
- IgG2
- IgG3
- IgG4

658 ( 270-1290)
81.5 ( 110-550)
38.9 ( 13-250)
60.9 ( 7-530)

mg/dl
mg/dl
mg/dl
mg/dl
NewEngl JMed1999a; 340: 692-702
Clinical Findings

Level

Highest serum IgE level

> 2,000

10

Skin abscess

3-4

4

Retained primary teeth

>3

8

Fracture ( minor trauma)

1-2

4

New born rash

present

4

Eczema

severe

4

4-6

2

URI/year

Points

Candidiasis

fingernails

2

Other serious infection

empyema thoracis

4

Increased nasal width

1-2 SD

1

Scoring was done on
Dec 12, 2013

Total

43





Hyper IgE syndrome
Type?
- Sporadic,AD, AR
Gene Analysis
- STAT3-deficient
- DOCK8-deficient
- Tyk2-deficient
Supportive Care:
- O2 via mask with bag
- ETT with ventilator support :
PC mode, Fio2 0.5, PIP 15, PEEP 5, Rate 20 Ti 1
 ICD :
- For diagnosis
- For relieve symptom






Empirical Antibiotics :
- Meropenam IV 60 MKD ( 17 d)
- Vancomycin IV 40 MKD ( 7 d)
- Augmentin 90 MKD continued
Fluid IV
Monitoring:
- VS
- O2 sat
- Blood gas
- ICD content & volume
- Intake/output


Pleural fluid ( 12
56)
- volume = 350 ml
- character : turbid, purulent
- Gram’s stain: positive cocci in chain ( many)
- pH : 7
- RBC : 39,983 cells/cumm
- WBC : 45,530 cell/cumm ( PMN 81% M 19%)
- Protein : 5.6 g/dl
- Sugar : 1 mg/dl
- LDH : 7947 U/L
- AFB : negative
- Modified AFB : negative
- Wright stain : not found
Tracheal suction Gram’s stain: gram positive
cocci in chain & cluster
Cultures :
- Pleural fluid: no growth after 48 hr
( aerobe & anaerobe)
- Hemo : no growth after 48 hr
- Urine : no growth
- Tracheal suction: no pathogenic organism
detected
ICD content: To identify bacteria by base sequencing
(pending)
Dec 15, 2013
- Off ETT , on O2 mask with bag 10 LPM
- Subcutaneous emphysema, revised ICD
- Serum galacto-mannan sample index = 0.21 ( > 0.5)
Dec 18, 2013
- Clinical improved
Dec 23, 2013
- ICD content = 0 ml
Dec 24, 2013
- Off ICD
- Chest PT, Cliniflow


-

Pleural fluid ( Dec 20, 2013)
- Content: Sero-purulent fluid
- Volume : 80 ml
- pH : 6.9
- RBC: 9382 cell/cumm
- WBC : 12422 cell/cumm ( N 48, M 19)
- Protein : 4.8 g/dl
- Sugar : 1 mg/dl
- LDH : 2090 U/L
Pleural fluid C.I.E. : Strep pneumoniae 100% by
NCBI Blast Search
Blood for PHA ( pending)
Pneumococcal titer Ab ( pending)
Anti HBs Ab: Negative ( > 10)
Fungal C/S : NG ( Dec, 12 )
Tip cath C/S : NG ( Dec, 24)








No evidence of lung mass
Retained ICD at left pleural cavity
Small left lung volume with diffuse smooth
pleural thickening along lingular segment of
LUL & LLL ( could be from chronic infection or
inflammation)
Near total atelectasis of lingular segment
LUL, containing focal consolidation
Passive atelectasis & small amount of left
pleural effusion
Hyper IgE syndrome:
- A primary immunodeficiency marked by
abnormalities in the coordination of cell–cell
signaling with the potential to affect TH17 cell, B
cell, and neutrophil responses
- Clinical manifestations include recurrent skin
and lung infections, serum IgE elevation, connective
tissue repair and development alterations, &
vascular abnormalities & tumor development etc.






Job’s syndrome: described in 1966
Reference to the Biblical Job who was “ smote
with sore boils”
Incidence in western countries
- 1/ 1 million
- Male: female 1:1

http:// orpha.net/consor




AD-Hyper-IgE Syndrome ( STAT3 Deficient)
AR-Hyper-IgE Syndrome ( DOCK8 Deficient)
AR-Hyper-IgE Syndrome ( Tyk2 Deficient)


Newborn rash on face & scalp ( pustular)
- Worsen by S.aureus
- After NB period, cutaneous abscess, mucocutaneous candidiasis,
infected dermatitis of axilla & groin etc.

Recurrent pneumonia in early childhood
- S. aureus is the commonest followed by Strep. pneumoniae, H. influenzae
- Purulent sputum, but lack of fever & systemic signs of inflammation
- Pneumatocele & bronchiectasis that accumulate aspergillosis &
gram negative bacteria



- Molds invade blood vessels & resulting to hemoptysis & disseminated
infection
-Other opportunistic infections; Pneumocystis jiroveci, histoplasmosis,
muco-cutaneous candidiasis


Somatic Features:
- Face; asymmetry, broad fleshy nose, & porous
skin
- Neurological; Arnold-Chiari I malformation(20%
of cases), cranio-synostosis no surgery needed
- Bone; minimal trauma fractures, osteopenia,
hyper-extensibility, scoliosis & joint degeneration


Somatic Features:
- Failure of primary teeth extraction
- Vascular abnormalities; aneurysm, lacunar
infarction
- Malignancy; non-Hodgkin, Hodgkin & leukemia
- Esophageal dysfunction


French cohort study :
- Necker Enfants Malades Hospital, Paris
- Detailed questionnaires completed by
physicians
- Clinical & labs collected from birth until
Feb 2011 or their death
- National Institutes of Health scoring system
- Score> 40 : likely to carry AD-HIES phenotype
- Score 20-40 : inconclusive
- Score < 20 : unlikely







CBC; eosinophilia
Serum IgE ; high ( > 2,000 IU/ul) but normal
IgG, IgA, & IgM levels
Decreased memory T-cell
Vary in Ab response
Gene analysis
CD 27: Memory B-cell marker










Higher rate of viral infections ( M. contagiosum
H. simplex, V. zoster)
Higher food & environmental allergy
Higher otitis media & sinusitis
Higher mortality rate from sepsis
Higher neurological features: hemiplegia,
CNS vasculitis
Higher rate of malignancy: T-cell leukemialymphoma
Severe eczema, skin infection, pneumonia are
common but NO pneumatocele



Rare features: typical face, bone abnormalities
Labs:
- Increased serum IgE, eosinophil
- Low absolute lymphocyte count, total T-cell
- Low CD4, CD8 count, normal CD4/CD8 ratio
- Decreased IgM, others vary
Only 2 cases reported (Turkish & Japanese)
No typical facial features, bone abnormalities
The Turkish patient had axillary lymphadenitis
from BCG & neuro-brucellosis after ingested
un-pasturized cheese, later developed brain
infarction
- The Japanese patient had dermatitis, skin infectios,
oral candidiasis, sinusitis, pneumonia, molluscum
contagiosum etc.
-


STAT 3 gene:
- Located on chromosome 17 q21
- Encodes a transcription factors
- Work in the process of STAT1, STAT4
- Translocate to nucleus
- Transcription >> affect to cytokines


STATE 3 Gene:
- IL-6 family, IL-10 family, IL-12 family,IL-21
G-CSF, leptin
- Associated with G protein-coupled receptor
signaling
- Association with cellular homeostasis ( involve
mitochondrial regulation of reactive oxygen
species generation)


STAT3 Function
- Intracellular cytokine receptor binds to one
of four JAK protein ( JAK 1,2,3 & Tyk2)
- Enhance STAT recruitment & phosphorylation
- Phosphorylated STAT dimerized by Src homology2
( SH2) domain >>> nucleus , then activate STATregulated genes
Coiled-coil domain
- Interact with other protein
 DNA-binding domain
- Transcriptional regulation
 Src homology 2 ( SH2) domain
- STAT protein dimerization & receptor contact
 Gene splice site/trans activation site
- Gene transcription
“Dominant negative mutation” contribute to
AD-HIES & decreased Th17 cell


JACI


STAT3 Function
- Clinical phenotypes of HIES :
-Excessive inflammation; prolonged inflammation
in lungs (pneumatocele)
- Inadequate inflammation; “cold” boils


In vitro:
- Increased pro-inflammatory cytokines eg.
TNF-alpha, IFN-gamma, IL-12 after stimulated
by specific agonist




In mouse & human: STAT3 integrate to Th17 cell
differentiation & IL-17 production
In HIES: near total absence of Th17 cell & impaired
IL-17 resulting in
- Impair host defense through recruitment of neutrophil
- Impair up-regulation of antimicrobial peptide
- Prone to candida & Klebsiella infection
- Impaired beta-defensin production ( prone to
S. aureus infection)


Why increased IgE in HIES
- Hypothesis: impaired IL-21 signaling since
IL-21 receptor knock out mice showed
increased IgE


DOCK 8 Signaling:
- Located on chromosome 9p24
- Loss of DOCK8 protein function is the most
common form of AR-HIES
- Role of DOCK8 ; activate Rho GTPase that
affects to actin cytoskeletal rearrangement


DOCK 8 Mutation:
- DOCK homology region 1 ( DHR1) domain
( for binding phosphatidylinositol3,4,5triphosphate membrane-rich region)
- DOCK homology region 2 ( DHR 2) domain
( for binding to Rho family GTPase)







DOCK8 expressed in B,T cells
DOCK8 HIES : impair immunity along various
stages of B,T cells development
Decreased CD8 T cell stimulation
Decreased CD8 T cell clonal proliferation
Decreased CD8 memory T cell




Tyk 2 located on chromosome 19p13.2
In a family of Janus kinase molecules
Roles:
- Transduces signal which transmitted from
type 1 IFN receptor, cytokine receptor
sharing IL-12RB1 subunit, cytokine receptor
sharing a gp 130 subunit & IL-13


Tyk2 components:
1) FERM domain
( localizes protein to plasma membrane)
2) SH2 domain
( modulate regulation of intracellular signaling
cascade)
3) Kinase domain
( phosphorylate target protein )


Homozygous deletion mutation:
- Impaired Th1 response, risk for mycobacteria
- Decreased IFN-gamma secretion by IL-12
stimulated splenocyte
- Impaired Th 17 response , risk for fungal
infection


Criteria***

NewEngl JMed1999a; 340: 692-702
STAT 3 mutation analysis is commercially available
 By using “ high-resolution PCR-based DNA-melting
assays” to identify & screen patients
 Quicker & cheaper than genome sequencing
 The variant can be confirmed by targeted
sequencing analysis
 No phenotype/genotype relationship among STAT3
mutation identified
For DOCK 8 & Tyk 2 mutation only available in special
research institute










Supportive management
Adequate treatment in pneumonia
Bronchoscope yields for isolating microbe & removing
pus
Pneumatocele & bronchiectasis need broad spectrum
ABT to cover gram negative & fungi
Skin:
- Eczema care & staphylococcal prevention by bathing
in bleach or swimming in chlorinated swimming pools
Prophylaxis antibiotic
- Co-trimoxazole
- Penicillinase-resistant penicillin
- Cephalosporin
Case report:
- An-8-y-old boy
- Diagnosed as HIES
- Prophylaxis with cloxacillin 30 MKD and Isotretinoin
- Free from skin infection for 26 months
- After discontinue medication, re-infection with fever,
otitis externa & cellulitis


360

Archives of Medical Research 35 (2004) 359–







IVIG :
- The most common immuno-modulator using
in HIES
- Decreased number of infection
IFN-gamma:
- Mixed results
Antihistamine –H2 & ciclosporin may help
BMT : AR-HIES with DOCK8 mutation cases
cured with hematopoietic cell transplantation


IVIG: From French Study
- From 32/60 ( 54%) received 400-500 mg/kg q
3-4 wk by IV, some cases used 100 mg/kg SC q wk
- NIH score 40
- The mean age when initiation 14 y( range, 1-39 y)
- Comparing incidence of bacterial pneumonia:
- IVIG group; 9.3/100 pt/y
- Non- IVIG group ; 27.8/100 pt/y




Based on recurrence of pyogenic bacterial
infection & memory B-cell lymphopenia
An accelerated decline of specific Ab titers after
initially normal primary Ab response &
lower than normal secondary Ab response

Clin Immunol 2008; 129:448-454


Antifungal prophylaxis:
- In case of structural airway abnormalities
- Mechanism; local epithelial impairment after
recurrent bacterial pneumonia similar in cystic
fibrosis or post-tuberculosis cavities
- Prophylactic surgery


Omalizumab:
- A – 32 –Y-old Thai female
- NIH Scoring = 30
- Serum IgE > 2,000 iu/ml ( 10 pts)
- Eosinophilia > 800 cell/ul ( 6 pts)
- Severe eczema ( 4 pts)
- Candidiasis of nails ( 2 pts)
- Recurrent skin abscess ( 8)
APJAI 2009; 27: 233-236


Omalizumab:
- Firstly tried topical steroid & tacrolimus
- Then, systemic steroid 30 mg/d, but flare up
after dose tapering
- Tried Omalizumab 300 mg SC q 2 wk, clinical
improve after 1 month & gradually decreased
systemic steroid

APJAI 2009; 27: 233-236
Causes of Death in HIES
JACI 2007; 119: 1234-40
JACI 2007; 119: 1234-40
JACI 2007; 119: 1234-40




A rare primary immunodeficiency marked by
abnormalities in the coordination of cell–cell
signaling with the potential to affect TH17
cell, B cell, and neutrophil responses
Clinical manifestations include recurrent skin
and lung infections, serum IgE
elevation, connective tissue repair and
development alterations






STAT3 –HIES:
- Pneumonia, pneumatocele, facial features,
bone abnormalities
DOCK 8 –HIES:
- Viral skin infections, sepsis, neurological,
malignancy, food allergy, decreased IgM
Tyk 2-HIES:
- Viral skin infections, sepsis, neurological




Investigations:
- Eosinophilia
- Hyper IgE
- Decreased memory B cell
- Decreased Th17 cell & IL-17
- Decreased T cell development
Diagnosis
- NIH scoring system
- High-resolution PCR-based DNA-melting
assays




Managements:
- Supportive
- ABT treatment
- ABT & antifungal prophylaxis
- Skin care
- IVIG
Causes of death:
- Infection
- Pulmonary hemorrhage
THANK YOU VERY MUCH

More Related Content

What's hot

Approach to a child with suspected Immunodeficiency
Approach to a child with suspected ImmunodeficiencyApproach to a child with suspected Immunodeficiency
Approach to a child with suspected Immunodeficiency
DrDilip86
 
Approach to primary immunodeficiency
Approach to primary immunodeficiency Approach to primary immunodeficiency
Approach to primary immunodeficiency
abdullah alzahrani
 
Hyper IgM syndrome
Hyper IgM syndromeHyper IgM syndrome
Hereditary angioedema and bradykinin-mediated angioedema
Hereditary angioedema and bradykinin-mediated angioedemaHereditary angioedema and bradykinin-mediated angioedema
Hereditary angioedema and bradykinin-mediated angioedema
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Seminar primary immunodeficiency syndrome
Seminar primary immunodeficiency syndromeSeminar primary immunodeficiency syndrome
Seminar primary immunodeficiency syndrome
Ekta Jajodia
 
Chronic granulomatous disease
Chronic granulomatous diseaseChronic granulomatous disease
Autoinflammatory syndromes
Autoinflammatory syndromesAutoinflammatory syndromes
Autoinflammatory syndromes
Medesun Healthcare Solutions LLC
 
Approach to phagocyte dysfunctions
Approach to phagocyte dysfunctionsApproach to phagocyte dysfunctions
Common variable immunodeficiency
Common variable immunodeficiencyCommon variable immunodeficiency
Common variable immunodeficiency
Common variable immunodeficiencyCommon variable immunodeficiency
Approach to child with histiocytosis
Approach to child with histiocytosisApproach to child with histiocytosis
Approach to child with histiocytosis
eram sid
 
Common variable immunodeficiency
Common variable immunodeficiencyCommon variable immunodeficiency
Henoch scholein purpura
Henoch scholein purpuraHenoch scholein purpura
Henoch scholein purpura
Dr. Saad Saleh Al Ani
 
Hemophagocytic Lymphohistiocytosis.pptx
Hemophagocytic Lymphohistiocytosis.pptxHemophagocytic Lymphohistiocytosis.pptx
Hemophagocytic Lymphohistiocytosis.pptx
Dr. Renesha Islam
 
Hypersensitivity pneumonitis
Hypersensitivity pneumonitisHypersensitivity pneumonitis
Selective ig a deficiency
Selective ig a deficiencySelective ig a deficiency
Selective ig a deficiency
Fatima Awadh
 
Non resolving pneumonia
Non resolving pneumoniaNon resolving pneumonia
Non resolving pneumonia
Saint Vincent Hospital
 
ANCA
ANCA ANCA
Chronic granulomatous disease (cgd)
Chronic granulomatous disease (cgd)Chronic granulomatous disease (cgd)
Chronic granulomatous disease (cgd)
bushbabys
 
Laboratory diagnosis of primary immunodeficiencies
Laboratory diagnosis of primary immunodeficienciesLaboratory diagnosis of primary immunodeficiencies
Laboratory diagnosis of primary immunodeficiencies
Chulalongkorn Allergy and Clinical Immunology Research Group
 

What's hot (20)

Approach to a child with suspected Immunodeficiency
Approach to a child with suspected ImmunodeficiencyApproach to a child with suspected Immunodeficiency
Approach to a child with suspected Immunodeficiency
 
Approach to primary immunodeficiency
Approach to primary immunodeficiency Approach to primary immunodeficiency
Approach to primary immunodeficiency
 
Hyper IgM syndrome
Hyper IgM syndromeHyper IgM syndrome
Hyper IgM syndrome
 
Hereditary angioedema and bradykinin-mediated angioedema
Hereditary angioedema and bradykinin-mediated angioedemaHereditary angioedema and bradykinin-mediated angioedema
Hereditary angioedema and bradykinin-mediated angioedema
 
Seminar primary immunodeficiency syndrome
Seminar primary immunodeficiency syndromeSeminar primary immunodeficiency syndrome
Seminar primary immunodeficiency syndrome
 
Chronic granulomatous disease
Chronic granulomatous diseaseChronic granulomatous disease
Chronic granulomatous disease
 
Autoinflammatory syndromes
Autoinflammatory syndromesAutoinflammatory syndromes
Autoinflammatory syndromes
 
Approach to phagocyte dysfunctions
Approach to phagocyte dysfunctionsApproach to phagocyte dysfunctions
Approach to phagocyte dysfunctions
 
Common variable immunodeficiency
Common variable immunodeficiencyCommon variable immunodeficiency
Common variable immunodeficiency
 
Common variable immunodeficiency
Common variable immunodeficiencyCommon variable immunodeficiency
Common variable immunodeficiency
 
Approach to child with histiocytosis
Approach to child with histiocytosisApproach to child with histiocytosis
Approach to child with histiocytosis
 
Common variable immunodeficiency
Common variable immunodeficiencyCommon variable immunodeficiency
Common variable immunodeficiency
 
Henoch scholein purpura
Henoch scholein purpuraHenoch scholein purpura
Henoch scholein purpura
 
Hemophagocytic Lymphohistiocytosis.pptx
Hemophagocytic Lymphohistiocytosis.pptxHemophagocytic Lymphohistiocytosis.pptx
Hemophagocytic Lymphohistiocytosis.pptx
 
Hypersensitivity pneumonitis
Hypersensitivity pneumonitisHypersensitivity pneumonitis
Hypersensitivity pneumonitis
 
Selective ig a deficiency
Selective ig a deficiencySelective ig a deficiency
Selective ig a deficiency
 
Non resolving pneumonia
Non resolving pneumoniaNon resolving pneumonia
Non resolving pneumonia
 
ANCA
ANCA ANCA
ANCA
 
Chronic granulomatous disease (cgd)
Chronic granulomatous disease (cgd)Chronic granulomatous disease (cgd)
Chronic granulomatous disease (cgd)
 
Laboratory diagnosis of primary immunodeficiencies
Laboratory diagnosis of primary immunodeficienciesLaboratory diagnosis of primary immunodeficiencies
Laboratory diagnosis of primary immunodeficiencies
 

Viewers also liked

FOTODERMATOSIS
FOTODERMATOSISFOTODERMATOSIS
FOTODERMATOSIS
Antonio Montoya
 
Hyper Ig M syndrome
Hyper Ig M syndromeHyper Ig M syndrome
Sesion de inmunodeficiencias
Sesion de inmunodeficienciasSesion de inmunodeficiencias
Sesion de inmunodeficiencias
APap IB
 
Format 2016: masqueradesyndromes in allergicdiseases.
Format 2016: masqueradesyndromes in allergicdiseases.Format 2016: masqueradesyndromes in allergicdiseases.
Format 2016: masqueradesyndromes in allergicdiseases.
Envicon Medical Srl
 
Approach to the child with immune based and allergic disease
Approach to the child with immune based and allergic diseaseApproach to the child with immune based and allergic disease
Approach to the child with immune based and allergic disease
Khaled Saad
 
FRAGILE X SYNDROME ( FXS ) an inherited cause of mental retardation.
FRAGILE X SYNDROME ( FXS ) an inherited cause of mental retardation.FRAGILE X SYNDROME ( FXS ) an inherited cause of mental retardation.
FRAGILE X SYNDROME ( FXS ) an inherited cause of mental retardation.
shhhoaib
 
Fragile x syndrome
Fragile x syndromeFragile x syndrome
Fragile x syndrome
Sayma Zerin
 
Fragile x syndrome
Fragile x syndromeFragile x syndrome
Fragile x syndrome
Sayma Zerin
 
Fragile X presentation
Fragile X presentationFragile X presentation
Fragile X presentation
Kelsey Sokol
 
Anaphylaxis
AnaphylaxisAnaphylaxis
Anaphylaxis
AnaphylaxisAnaphylaxis
Fragile X Syndrome
Fragile X SyndromeFragile X Syndrome
Fragile X Syndrome
khalid mansour
 
Fragile x syndrome
Fragile x syndrome Fragile x syndrome
Fragile x syndrome
Nik Syamimi
 
Mitochondrial diseases
Mitochondrial diseasesMitochondrial diseases
Mitochondrial diseases
Dr. Munish Kumar
 
Anaphylaxis
AnaphylaxisAnaphylaxis
Anaphylaxis
moduledesign
 
Dna fingerprinting
Dna fingerprintingDna fingerprinting
Dna fingerprinting
surendran aduthila
 
Dna fingerprinting
Dna fingerprintingDna fingerprinting
Dna fingerprinting
14cindta
 
Anaphylaxis
AnaphylaxisAnaphylaxis
Anaphylaxis
Fatima Awadh
 
Dna fingerprinting powerpoint
Dna fingerprinting powerpointDna fingerprinting powerpoint
Dna fingerprinting powerpoint
Genevia Vincent
 

Viewers also liked (20)

FOTODERMATOSIS
FOTODERMATOSISFOTODERMATOSIS
FOTODERMATOSIS
 
Immunodeficienze Congenite
Immunodeficienze CongeniteImmunodeficienze Congenite
Immunodeficienze Congenite
 
Hyper Ig M syndrome
Hyper Ig M syndromeHyper Ig M syndrome
Hyper Ig M syndrome
 
Sesion de inmunodeficiencias
Sesion de inmunodeficienciasSesion de inmunodeficiencias
Sesion de inmunodeficiencias
 
Format 2016: masqueradesyndromes in allergicdiseases.
Format 2016: masqueradesyndromes in allergicdiseases.Format 2016: masqueradesyndromes in allergicdiseases.
Format 2016: masqueradesyndromes in allergicdiseases.
 
Approach to the child with immune based and allergic disease
Approach to the child with immune based and allergic diseaseApproach to the child with immune based and allergic disease
Approach to the child with immune based and allergic disease
 
FRAGILE X SYNDROME ( FXS ) an inherited cause of mental retardation.
FRAGILE X SYNDROME ( FXS ) an inherited cause of mental retardation.FRAGILE X SYNDROME ( FXS ) an inherited cause of mental retardation.
FRAGILE X SYNDROME ( FXS ) an inherited cause of mental retardation.
 
Fragile x syndrome
Fragile x syndromeFragile x syndrome
Fragile x syndrome
 
Fragile x syndrome
Fragile x syndromeFragile x syndrome
Fragile x syndrome
 
Fragile X presentation
Fragile X presentationFragile X presentation
Fragile X presentation
 
Anaphylaxis
AnaphylaxisAnaphylaxis
Anaphylaxis
 
Anaphylaxis
AnaphylaxisAnaphylaxis
Anaphylaxis
 
Fragile X Syndrome
Fragile X SyndromeFragile X Syndrome
Fragile X Syndrome
 
Fragile x syndrome
Fragile x syndrome Fragile x syndrome
Fragile x syndrome
 
Mitochondrial diseases
Mitochondrial diseasesMitochondrial diseases
Mitochondrial diseases
 
Anaphylaxis
AnaphylaxisAnaphylaxis
Anaphylaxis
 
Dna fingerprinting
Dna fingerprintingDna fingerprinting
Dna fingerprinting
 
Dna fingerprinting
Dna fingerprintingDna fingerprinting
Dna fingerprinting
 
Anaphylaxis
AnaphylaxisAnaphylaxis
Anaphylaxis
 
Dna fingerprinting powerpoint
Dna fingerprinting powerpointDna fingerprinting powerpoint
Dna fingerprinting powerpoint
 

Similar to Hyper IgE syndrome

Leptospirosis case presentation
Leptospirosis case presentationLeptospirosis case presentation
Leptospirosis case presentation
DR MUKESH SAH
 
Caso completo
Caso completoCaso completo
Caso completo
AntoniVanrell
 
Gram Negative Sepsis
Gram Negative SepsisGram Negative Sepsis
Gram Negative Sepsis
shabeel pn
 
New ulmonary arterial hypertension in rheumatic diseases
New ulmonary arterial hypertension in rheumatic diseases New ulmonary arterial hypertension in rheumatic diseases
New ulmonary arterial hypertension in rheumatic diseases
財團法人風濕病基金會台灣抗風濕病聯盟
 
Pulmonary Sarcoidosis
Pulmonary SarcoidosisPulmonary Sarcoidosis
Pulmonary Sarcoidosis
Sarfraz Saleemi
 
Unusual Cause of Pulmonary Hypertension
Unusual Cause of Pulmonary HypertensionUnusual Cause of Pulmonary Hypertension
Unusual Cause of Pulmonary Hypertension
Stanley Medical College, Department of Medicine
 
A Case of Splenic Tuberculosis
A Case of Splenic TuberculosisA Case of Splenic Tuberculosis
A Case of Splenic Tuberculosis
Stanley Medical College, Department of Medicine
 
Case pancretitis
Case pancretitisCase pancretitis
Case pancretitis
Kamal Mergani
 
Clinical meet
Clinical meetClinical meet
Clinical meet
ajit jadhav
 
A Case of Antiphospholipid Antibody Syndrome
A Case of Antiphospholipid Antibody SyndromeA Case of Antiphospholipid Antibody Syndrome
A Case of Antiphospholipid Antibody Syndrome
Stanley Medical College, Department of Medicine
 
Pulmonary Renal Syndorme
Pulmonary Renal Syndorme Pulmonary Renal Syndorme
Pulmonary Renal Syndorme
Farhan Tahir MD, FACR, Diplomate ABIHM
 
Churg Strauss Syndrome
Churg Strauss SyndromeChurg Strauss Syndrome
meningio.pptx
meningio.pptxmeningio.pptx
meningio.pptx
MebratGebreyesus
 
A Case of Henoch-Schonlein Purpura
A Case of Henoch-Schonlein PurpuraA Case of Henoch-Schonlein Purpura
A Case of Henoch-Schonlein Purpura
Stanley Medical College, Department of Medicine
 
Case Study on Reteropositive with RF,LRTI,UTI and Sepsis .pptx
Case Study on Reteropositive with RF,LRTI,UTI and Sepsis .pptxCase Study on Reteropositive with RF,LRTI,UTI and Sepsis .pptx
Case Study on Reteropositive with RF,LRTI,UTI and Sepsis .pptx
Kamaljeet ..
 
Right sided valve infective endocarditis by dr adeel
Right sided valve infective endocarditis by dr adeelRight sided valve infective endocarditis by dr adeel
Right sided valve infective endocarditis by dr adeel
West Medicine Ward
 
Wonca Europe 2014, Lisbon: anamnesis
Wonca Europe 2014, Lisbon: anamnesisWonca Europe 2014, Lisbon: anamnesis
Wonca Europe 2014, Lisbon: anamnesis
B. Jiménez
 
Leptomeningeal metastases, differential diagnosis. CPC
Leptomeningeal metastases, differential diagnosis. CPCLeptomeningeal metastases, differential diagnosis. CPC
Leptomeningeal metastases, differential diagnosis. CPC
Neurology Residency
 
cerebral toxoplasmosis
cerebral toxoplasmosiscerebral toxoplasmosis
cerebral toxoplasmosis
Mehakinder Singh
 
A Case of Osler-Rendu-Weber syndrome
A Case of Osler-Rendu-Weber syndromeA Case of Osler-Rendu-Weber syndrome
A Case of Osler-Rendu-Weber syndrome
Stanley Medical College, Department of Medicine
 

Similar to Hyper IgE syndrome (20)

Leptospirosis case presentation
Leptospirosis case presentationLeptospirosis case presentation
Leptospirosis case presentation
 
Caso completo
Caso completoCaso completo
Caso completo
 
Gram Negative Sepsis
Gram Negative SepsisGram Negative Sepsis
Gram Negative Sepsis
 
New ulmonary arterial hypertension in rheumatic diseases
New ulmonary arterial hypertension in rheumatic diseases New ulmonary arterial hypertension in rheumatic diseases
New ulmonary arterial hypertension in rheumatic diseases
 
Pulmonary Sarcoidosis
Pulmonary SarcoidosisPulmonary Sarcoidosis
Pulmonary Sarcoidosis
 
Unusual Cause of Pulmonary Hypertension
Unusual Cause of Pulmonary HypertensionUnusual Cause of Pulmonary Hypertension
Unusual Cause of Pulmonary Hypertension
 
A Case of Splenic Tuberculosis
A Case of Splenic TuberculosisA Case of Splenic Tuberculosis
A Case of Splenic Tuberculosis
 
Case pancretitis
Case pancretitisCase pancretitis
Case pancretitis
 
Clinical meet
Clinical meetClinical meet
Clinical meet
 
A Case of Antiphospholipid Antibody Syndrome
A Case of Antiphospholipid Antibody SyndromeA Case of Antiphospholipid Antibody Syndrome
A Case of Antiphospholipid Antibody Syndrome
 
Pulmonary Renal Syndorme
Pulmonary Renal Syndorme Pulmonary Renal Syndorme
Pulmonary Renal Syndorme
 
Churg Strauss Syndrome
Churg Strauss SyndromeChurg Strauss Syndrome
Churg Strauss Syndrome
 
meningio.pptx
meningio.pptxmeningio.pptx
meningio.pptx
 
A Case of Henoch-Schonlein Purpura
A Case of Henoch-Schonlein PurpuraA Case of Henoch-Schonlein Purpura
A Case of Henoch-Schonlein Purpura
 
Case Study on Reteropositive with RF,LRTI,UTI and Sepsis .pptx
Case Study on Reteropositive with RF,LRTI,UTI and Sepsis .pptxCase Study on Reteropositive with RF,LRTI,UTI and Sepsis .pptx
Case Study on Reteropositive with RF,LRTI,UTI and Sepsis .pptx
 
Right sided valve infective endocarditis by dr adeel
Right sided valve infective endocarditis by dr adeelRight sided valve infective endocarditis by dr adeel
Right sided valve infective endocarditis by dr adeel
 
Wonca Europe 2014, Lisbon: anamnesis
Wonca Europe 2014, Lisbon: anamnesisWonca Europe 2014, Lisbon: anamnesis
Wonca Europe 2014, Lisbon: anamnesis
 
Leptomeningeal metastases, differential diagnosis. CPC
Leptomeningeal metastases, differential diagnosis. CPCLeptomeningeal metastases, differential diagnosis. CPC
Leptomeningeal metastases, differential diagnosis. CPC
 
cerebral toxoplasmosis
cerebral toxoplasmosiscerebral toxoplasmosis
cerebral toxoplasmosis
 
A Case of Osler-Rendu-Weber syndrome
A Case of Osler-Rendu-Weber syndromeA Case of Osler-Rendu-Weber syndrome
A Case of Osler-Rendu-Weber syndrome
 

More from Chulalongkorn Allergy and Clinical Immunology Research Group

Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Hereditary angioedema & bradykinin-mediated angioedema.pdf
Hereditary angioedema & bradykinin-mediated angioedema.pdfHereditary angioedema & bradykinin-mediated angioedema.pdf
Hereditary angioedema & bradykinin-mediated angioedema.pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Contact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdfContact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
HyperIgE syndrome: primary immune deficiency.pdf
HyperIgE syndrome: primary immune deficiency.pdfHyperIgE syndrome: primary immune deficiency.pdf
HyperIgE syndrome: primary immune deficiency.pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Adverse reactions and allergic reactions to food additives
Adverse reactions and allergic reactions to food additivesAdverse reactions and allergic reactions to food additives
Adverse reactions and allergic reactions to food additives
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Glucocorticoids: mechanisms of actions and clinical implications
Glucocorticoids: mechanisms of actions and clinical implicationsGlucocorticoids: mechanisms of actions and clinical implications
Glucocorticoids: mechanisms of actions and clinical implications
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Asthma part 1: pathogenesis, diagnosis, and endotypes
Asthma part 1: pathogenesis, diagnosis, and endotypesAsthma part 1: pathogenesis, diagnosis, and endotypes
Asthma part 1: pathogenesis, diagnosis, and endotypes
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Cat and dog allergy and exotic pets 2024
Cat and dog allergy and exotic pets 2024Cat and dog allergy and exotic pets 2024
Cat and dog allergy and exotic pets 2024
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Anti-interferon-gamma autoantibody associated immunodeficiency
Anti-interferon-gamma autoantibody associated immunodeficiencyAnti-interferon-gamma autoantibody associated immunodeficiency
Anti-interferon-gamma autoantibody associated immunodeficiency
Chulalongkorn Allergy and Clinical Immunology Research Group
 
DRESS syndrome.pdf
DRESS syndrome.pdfDRESS syndrome.pdf
Wheat allergy.pdf
Wheat allergy.pdfWheat allergy.pdf
Indoor allergen avoidance.pdf
Indoor allergen avoidance.pdfIndoor allergen avoidance.pdf
Hymenoptera sting allergy.pdf
Hymenoptera sting allergy.pdfHymenoptera sting allergy.pdf
AERD and NSAID hypersensitivity
AERD and NSAID hypersensitivityAERD and NSAID hypersensitivity
Food immunotherapy.pdf
Food immunotherapy.pdfFood immunotherapy.pdf
Agammaglobulinemia.pdf
Agammaglobulinemia.pdfAgammaglobulinemia.pdf
Histamine and anti histamines.pdf
Histamine and anti histamines.pdfHistamine and anti histamines.pdf
Food-dependent, exercise-induced anaphylaxis
Food-dependent, exercise-induced anaphylaxis Food-dependent, exercise-induced anaphylaxis
Food-dependent, exercise-induced anaphylaxis
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Beta-lactam allergy.pdf
Beta-lactam allergy.pdfBeta-lactam allergy.pdf
Immunoglobulin therapy
Immunoglobulin therapyImmunoglobulin therapy

More from Chulalongkorn Allergy and Clinical Immunology Research Group (20)

Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
 
Hereditary angioedema & bradykinin-mediated angioedema.pdf
Hereditary angioedema & bradykinin-mediated angioedema.pdfHereditary angioedema & bradykinin-mediated angioedema.pdf
Hereditary angioedema & bradykinin-mediated angioedema.pdf
 
Contact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdfContact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdf
 
HyperIgE syndrome: primary immune deficiency.pdf
HyperIgE syndrome: primary immune deficiency.pdfHyperIgE syndrome: primary immune deficiency.pdf
HyperIgE syndrome: primary immune deficiency.pdf
 
Adverse reactions and allergic reactions to food additives
Adverse reactions and allergic reactions to food additivesAdverse reactions and allergic reactions to food additives
Adverse reactions and allergic reactions to food additives
 
Glucocorticoids: mechanisms of actions and clinical implications
Glucocorticoids: mechanisms of actions and clinical implicationsGlucocorticoids: mechanisms of actions and clinical implications
Glucocorticoids: mechanisms of actions and clinical implications
 
Asthma part 1: pathogenesis, diagnosis, and endotypes
Asthma part 1: pathogenesis, diagnosis, and endotypesAsthma part 1: pathogenesis, diagnosis, and endotypes
Asthma part 1: pathogenesis, diagnosis, and endotypes
 
Cat and dog allergy and exotic pets 2024
Cat and dog allergy and exotic pets 2024Cat and dog allergy and exotic pets 2024
Cat and dog allergy and exotic pets 2024
 
Anti-interferon-gamma autoantibody associated immunodeficiency
Anti-interferon-gamma autoantibody associated immunodeficiencyAnti-interferon-gamma autoantibody associated immunodeficiency
Anti-interferon-gamma autoantibody associated immunodeficiency
 
DRESS syndrome.pdf
DRESS syndrome.pdfDRESS syndrome.pdf
DRESS syndrome.pdf
 
Wheat allergy.pdf
Wheat allergy.pdfWheat allergy.pdf
Wheat allergy.pdf
 
Indoor allergen avoidance.pdf
Indoor allergen avoidance.pdfIndoor allergen avoidance.pdf
Indoor allergen avoidance.pdf
 
Hymenoptera sting allergy.pdf
Hymenoptera sting allergy.pdfHymenoptera sting allergy.pdf
Hymenoptera sting allergy.pdf
 
AERD and NSAID hypersensitivity
AERD and NSAID hypersensitivityAERD and NSAID hypersensitivity
AERD and NSAID hypersensitivity
 
Food immunotherapy.pdf
Food immunotherapy.pdfFood immunotherapy.pdf
Food immunotherapy.pdf
 
Agammaglobulinemia.pdf
Agammaglobulinemia.pdfAgammaglobulinemia.pdf
Agammaglobulinemia.pdf
 
Histamine and anti histamines.pdf
Histamine and anti histamines.pdfHistamine and anti histamines.pdf
Histamine and anti histamines.pdf
 
Food-dependent, exercise-induced anaphylaxis
Food-dependent, exercise-induced anaphylaxis Food-dependent, exercise-induced anaphylaxis
Food-dependent, exercise-induced anaphylaxis
 
Beta-lactam allergy.pdf
Beta-lactam allergy.pdfBeta-lactam allergy.pdf
Beta-lactam allergy.pdf
 
Immunoglobulin therapy
Immunoglobulin therapyImmunoglobulin therapy
Immunoglobulin therapy
 

Recently uploaded

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 

Recently uploaded (20)

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 

Hyper IgE syndrome

  • 3.  CC: refer PI: 5d PTA 3 d PTA 4 2 d PTA 10 ( 1 2546) , multiple admissions ( 12 1 56)
  • 4.  PI : ( ) VS: BT 37.5 C,RR 80/min, PR 104/min, BP145/81 Oxygen Sat room air 94% , Lungs: Decreased breath sound LLL CXR : Massive left pleural effusion with tracheal shift to the right, single soft tissue mass at right hilar region
  • 5.  PI 14% CBC: Hb 11 Hct 34 WBC 4140 N 79% L BUN/Cr : 22/0.5 E’lyte : Na 134 K 4.4 Cl 94 CO2 20 Impression : Left empyema thoracis & right lung abscess Refer
  • 6.  PH : - P1 - P2 - P3 - P4 : : G&D: 3 c/s BW 2,600 gm DFIU GA 36 wk 17-y-old female , healthy 15-y-old female, healthy 10-y-old male, patient ( 10 ) Vaccination: pneumococcal & ,
  • 7.  PH: Drug allergy: Nystatin ( urticaria ) Fluconazole ( urticaria ) Ketoconazole ( urticaria) Food allergy: Cow’s milk, egg, seafood, soy, wheat accidental exposure : On BF, Enfa ( flare up of AD, Nutramigen ( at 9 mon ) Neocate ( 10 mon -3 y) : Current foods; rice, chicken, pork, fish etc.
  • 8.  PH: Past Infections - At 2 m of age: Bacterial lymphadenitis : Common cold q 1 m : AD treated with Elidel, zyrtec - At 2 y of age : Bacterial lymphadenitis - At 4 y of age : Bacterial lymphadenitis - At 7 y of age : Bacterial lymphadenitis & multiple abscess at thigh _ At 4 y : Serum sIgE to foods ; class 3-4
  • 9.  PH: History of AD treatment 1m 1y - 5 m PTA Erythromycin ( 2wk) Prednisolone (5) 1*3 ( 6 wk) 2 - 2 m PTA
  • 10.  Physical Examination: - GA: A Thai boy, good consciousness, dyspnea, no cyanosis - VS : BT 37 c RR 60/min PR130/min BP 130/80 O2 sat 100% ( via mask with bag 6 L/min) BW 30 kg ( P50) - HEENT: mild pale conjunctiva, mild puffy eyelid with eczema on face, broad nasal base, no frontal bossing, LN impalpaple - Lungs : suprasternal & subcostal retraction decreased breath sound left side
  • 11.  Physical Examination Heart: normal s1 s2 , no murmur Abdomen: soft, not tender, no hepato-splenomegaly Extremities: no deformities, no edema, post inflammatory hyperpigmentation both legs, clubbing of fingers Skin: Dry, erythematous papule & scaly face , arms & legs. Paronhychia Neuro: intact
  • 12.
  • 13.  Problems: 1. Acute dyspnea with decreased breath sound left lung 2. Recurrent bacterial lymphadenitis 3. Recurrent eczema 4. History of multiple foods allergy 5. History of multiple drugs allergy 6. Mild anemia 7. Mild puffy eye lids 8. Broad nasal base 9. Clubbing of fingers 10. Paronychia
  • 14.  Primary Immunodeficiency diseases - Hyper IgE syndrome - CGD - CVID Active problems: - Lung abscess - Empyema thoracis - Pleural effusion
  • 15. DATE Dec 11,2013 Dec 13, 2013 Dec 16, 2013 RBC 3.53 3.15 3.98 HGB 10.7 9.6 11.5 HCT 32.5 29.1 35.4 MCV 92.1 92.2 92.4 WBC 2990 9280 14770 N ( %) 74.3 51.7 57.4 L ( %) 19.6 28.1 28.3 M (%) 3.0 10.4 12.7 E ( %) 1.1 6.4 0.6 B (%) 0.1 0.1 0.2 Abs NC 2212 4800 8480 Abs LC 586 2610 3740 Platelet 198,000 198,000 389,000 Abs Eo= 594
  • 16.                 WBC : 12,410 Abs total Lymphocyte : 3,115 Total Lymphocyte (%) : 25.1 Abs CD3 : 2,336 CD3 ( %) : 75 Abs CD4 : 1,433 CD4 (%) : 46 Abs CD8 : 748 CD8 (%) : 24 CD 19(%) : 23 CD 56(%) : 2 Hb Hct MCV MCH MCHC : : : : : 11.1 31.7 84.3 29.5 35
  • 18. 11 56 -BUN/Cr : - TB/DB : - ALP : - SGOT : - SGPT : - ALB : - GLOB : - TP : - LDH : 12/0.4 0.54/0.34 79 34 25 3.5 ( 16 ( 16 ( 16 238 56 = 3.8) 56 = 2.8) 56 = 6.6)
  • 19.  Immunoglobulin level: ( 12 56) - IgG 815 ( 889- 1359 ) mg/dl - IgM 72.6 ( 46- 112) mg/dl - IgA 79 ( 71-191) mg/dl - Total IgE 28,700 ( < 200) IU/ml - IgG1 - IgG2 - IgG3 - IgG4 658 ( 270-1290) 81.5 ( 110-550) 38.9 ( 13-250) 60.9 ( 7-530) mg/dl mg/dl mg/dl mg/dl
  • 20.
  • 22. Clinical Findings Level Highest serum IgE level > 2,000 10 Skin abscess 3-4 4 Retained primary teeth >3 8 Fracture ( minor trauma) 1-2 4 New born rash present 4 Eczema severe 4 4-6 2 URI/year Points Candidiasis fingernails 2 Other serious infection empyema thoracis 4 Increased nasal width 1-2 SD 1 Scoring was done on Dec 12, 2013 Total 43
  • 23.    Hyper IgE syndrome Type? - Sporadic,AD, AR Gene Analysis - STAT3-deficient - DOCK8-deficient - Tyk2-deficient
  • 24. Supportive Care: - O2 via mask with bag - ETT with ventilator support : PC mode, Fio2 0.5, PIP 15, PEEP 5, Rate 20 Ti 1  ICD : - For diagnosis - For relieve symptom 
  • 25.    Empirical Antibiotics : - Meropenam IV 60 MKD ( 17 d) - Vancomycin IV 40 MKD ( 7 d) - Augmentin 90 MKD continued Fluid IV Monitoring: - VS - O2 sat - Blood gas - ICD content & volume - Intake/output
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.  Pleural fluid ( 12 56) - volume = 350 ml - character : turbid, purulent - Gram’s stain: positive cocci in chain ( many) - pH : 7 - RBC : 39,983 cells/cumm - WBC : 45,530 cell/cumm ( PMN 81% M 19%) - Protein : 5.6 g/dl - Sugar : 1 mg/dl - LDH : 7947 U/L - AFB : negative - Modified AFB : negative - Wright stain : not found
  • 31. Tracheal suction Gram’s stain: gram positive cocci in chain & cluster Cultures : - Pleural fluid: no growth after 48 hr ( aerobe & anaerobe) - Hemo : no growth after 48 hr - Urine : no growth - Tracheal suction: no pathogenic organism detected ICD content: To identify bacteria by base sequencing (pending)
  • 32.
  • 33. Dec 15, 2013 - Off ETT , on O2 mask with bag 10 LPM - Subcutaneous emphysema, revised ICD - Serum galacto-mannan sample index = 0.21 ( > 0.5) Dec 18, 2013 - Clinical improved Dec 23, 2013 - ICD content = 0 ml Dec 24, 2013 - Off ICD - Chest PT, Cliniflow
  • 34.  - Pleural fluid ( Dec 20, 2013) - Content: Sero-purulent fluid - Volume : 80 ml - pH : 6.9 - RBC: 9382 cell/cumm - WBC : 12422 cell/cumm ( N 48, M 19) - Protein : 4.8 g/dl - Sugar : 1 mg/dl - LDH : 2090 U/L Pleural fluid C.I.E. : Strep pneumoniae 100% by NCBI Blast Search Blood for PHA ( pending) Pneumococcal titer Ab ( pending) Anti HBs Ab: Negative ( > 10) Fungal C/S : NG ( Dec, 12 ) Tip cath C/S : NG ( Dec, 24)
  • 35.
  • 36.
  • 37.      No evidence of lung mass Retained ICD at left pleural cavity Small left lung volume with diffuse smooth pleural thickening along lingular segment of LUL & LLL ( could be from chronic infection or inflammation) Near total atelectasis of lingular segment LUL, containing focal consolidation Passive atelectasis & small amount of left pleural effusion
  • 38. Hyper IgE syndrome: - A primary immunodeficiency marked by abnormalities in the coordination of cell–cell signaling with the potential to affect TH17 cell, B cell, and neutrophil responses - Clinical manifestations include recurrent skin and lung infections, serum IgE elevation, connective tissue repair and development alterations, & vascular abnormalities & tumor development etc. 
  • 39.    Job’s syndrome: described in 1966 Reference to the Biblical Job who was “ smote with sore boils” Incidence in western countries - 1/ 1 million - Male: female 1:1 http:// orpha.net/consor
  • 40.
  • 41.
  • 42.    AD-Hyper-IgE Syndrome ( STAT3 Deficient) AR-Hyper-IgE Syndrome ( DOCK8 Deficient) AR-Hyper-IgE Syndrome ( Tyk2 Deficient)
  • 43.  Newborn rash on face & scalp ( pustular) - Worsen by S.aureus - After NB period, cutaneous abscess, mucocutaneous candidiasis, infected dermatitis of axilla & groin etc. Recurrent pneumonia in early childhood - S. aureus is the commonest followed by Strep. pneumoniae, H. influenzae - Purulent sputum, but lack of fever & systemic signs of inflammation - Pneumatocele & bronchiectasis that accumulate aspergillosis & gram negative bacteria  - Molds invade blood vessels & resulting to hemoptysis & disseminated infection -Other opportunistic infections; Pneumocystis jiroveci, histoplasmosis, muco-cutaneous candidiasis
  • 44.  Somatic Features: - Face; asymmetry, broad fleshy nose, & porous skin - Neurological; Arnold-Chiari I malformation(20% of cases), cranio-synostosis no surgery needed - Bone; minimal trauma fractures, osteopenia, hyper-extensibility, scoliosis & joint degeneration
  • 45.
  • 46.  Somatic Features: - Failure of primary teeth extraction - Vascular abnormalities; aneurysm, lacunar infarction - Malignancy; non-Hodgkin, Hodgkin & leukemia - Esophageal dysfunction
  • 47.  French cohort study : - Necker Enfants Malades Hospital, Paris - Detailed questionnaires completed by physicians - Clinical & labs collected from birth until Feb 2011 or their death - National Institutes of Health scoring system - Score> 40 : likely to carry AD-HIES phenotype - Score 20-40 : inconclusive - Score < 20 : unlikely
  • 48.      CBC; eosinophilia Serum IgE ; high ( > 2,000 IU/ul) but normal IgG, IgA, & IgM levels Decreased memory T-cell Vary in Ab response Gene analysis
  • 49. CD 27: Memory B-cell marker
  • 50.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.
  • 57.        Higher rate of viral infections ( M. contagiosum H. simplex, V. zoster) Higher food & environmental allergy Higher otitis media & sinusitis Higher mortality rate from sepsis Higher neurological features: hemiplegia, CNS vasculitis Higher rate of malignancy: T-cell leukemialymphoma Severe eczema, skin infection, pneumonia are common but NO pneumatocele
  • 58.   Rare features: typical face, bone abnormalities Labs: - Increased serum IgE, eosinophil - Low absolute lymphocyte count, total T-cell - Low CD4, CD8 count, normal CD4/CD8 ratio - Decreased IgM, others vary
  • 59.
  • 60.
  • 61. Only 2 cases reported (Turkish & Japanese) No typical facial features, bone abnormalities The Turkish patient had axillary lymphadenitis from BCG & neuro-brucellosis after ingested un-pasturized cheese, later developed brain infarction - The Japanese patient had dermatitis, skin infectios, oral candidiasis, sinusitis, pneumonia, molluscum contagiosum etc. -
  • 62.
  • 63.  STAT 3 gene: - Located on chromosome 17 q21 - Encodes a transcription factors - Work in the process of STAT1, STAT4 - Translocate to nucleus - Transcription >> affect to cytokines
  • 64.  STATE 3 Gene: - IL-6 family, IL-10 family, IL-12 family,IL-21 G-CSF, leptin - Associated with G protein-coupled receptor signaling - Association with cellular homeostasis ( involve mitochondrial regulation of reactive oxygen species generation)
  • 65.  STAT3 Function - Intracellular cytokine receptor binds to one of four JAK protein ( JAK 1,2,3 & Tyk2) - Enhance STAT recruitment & phosphorylation - Phosphorylated STAT dimerized by Src homology2 ( SH2) domain >>> nucleus , then activate STATregulated genes
  • 66.
  • 67. Coiled-coil domain - Interact with other protein  DNA-binding domain - Transcriptional regulation  Src homology 2 ( SH2) domain - STAT protein dimerization & receptor contact  Gene splice site/trans activation site - Gene transcription “Dominant negative mutation” contribute to AD-HIES & decreased Th17 cell  JACI
  • 68.
  • 69.  STAT3 Function - Clinical phenotypes of HIES : -Excessive inflammation; prolonged inflammation in lungs (pneumatocele) - Inadequate inflammation; “cold” boils
  • 70.  In vitro: - Increased pro-inflammatory cytokines eg. TNF-alpha, IFN-gamma, IL-12 after stimulated by specific agonist
  • 71.
  • 72.   In mouse & human: STAT3 integrate to Th17 cell differentiation & IL-17 production In HIES: near total absence of Th17 cell & impaired IL-17 resulting in - Impair host defense through recruitment of neutrophil - Impair up-regulation of antimicrobial peptide - Prone to candida & Klebsiella infection - Impaired beta-defensin production ( prone to S. aureus infection)
  • 73.  Why increased IgE in HIES - Hypothesis: impaired IL-21 signaling since IL-21 receptor knock out mice showed increased IgE
  • 74.  DOCK 8 Signaling: - Located on chromosome 9p24 - Loss of DOCK8 protein function is the most common form of AR-HIES - Role of DOCK8 ; activate Rho GTPase that affects to actin cytoskeletal rearrangement
  • 75.  DOCK 8 Mutation: - DOCK homology region 1 ( DHR1) domain ( for binding phosphatidylinositol3,4,5triphosphate membrane-rich region) - DOCK homology region 2 ( DHR 2) domain ( for binding to Rho family GTPase)
  • 76.      DOCK8 expressed in B,T cells DOCK8 HIES : impair immunity along various stages of B,T cells development Decreased CD8 T cell stimulation Decreased CD8 T cell clonal proliferation Decreased CD8 memory T cell
  • 77.    Tyk 2 located on chromosome 19p13.2 In a family of Janus kinase molecules Roles: - Transduces signal which transmitted from type 1 IFN receptor, cytokine receptor sharing IL-12RB1 subunit, cytokine receptor sharing a gp 130 subunit & IL-13
  • 78.  Tyk2 components: 1) FERM domain ( localizes protein to plasma membrane) 2) SH2 domain ( modulate regulation of intracellular signaling cascade) 3) Kinase domain ( phosphorylate target protein )
  • 79.  Homozygous deletion mutation: - Impaired Th1 response, risk for mycobacteria - Decreased IFN-gamma secretion by IL-12 stimulated splenocyte - Impaired Th 17 response , risk for fungal infection
  • 81. STAT 3 mutation analysis is commercially available  By using “ high-resolution PCR-based DNA-melting assays” to identify & screen patients  Quicker & cheaper than genome sequencing  The variant can be confirmed by targeted sequencing analysis  No phenotype/genotype relationship among STAT3 mutation identified For DOCK 8 & Tyk 2 mutation only available in special research institute 
  • 82.      Supportive management Adequate treatment in pneumonia Bronchoscope yields for isolating microbe & removing pus Pneumatocele & bronchiectasis need broad spectrum ABT to cover gram negative & fungi Skin: - Eczema care & staphylococcal prevention by bathing in bleach or swimming in chlorinated swimming pools
  • 83. Prophylaxis antibiotic - Co-trimoxazole - Penicillinase-resistant penicillin - Cephalosporin Case report: - An-8-y-old boy - Diagnosed as HIES - Prophylaxis with cloxacillin 30 MKD and Isotretinoin - Free from skin infection for 26 months - After discontinue medication, re-infection with fever, otitis externa & cellulitis  360 Archives of Medical Research 35 (2004) 359–
  • 84.     IVIG : - The most common immuno-modulator using in HIES - Decreased number of infection IFN-gamma: - Mixed results Antihistamine –H2 & ciclosporin may help BMT : AR-HIES with DOCK8 mutation cases cured with hematopoietic cell transplantation
  • 85.  IVIG: From French Study - From 32/60 ( 54%) received 400-500 mg/kg q 3-4 wk by IV, some cases used 100 mg/kg SC q wk - NIH score 40 - The mean age when initiation 14 y( range, 1-39 y) - Comparing incidence of bacterial pneumonia: - IVIG group; 9.3/100 pt/y - Non- IVIG group ; 27.8/100 pt/y
  • 86.   Based on recurrence of pyogenic bacterial infection & memory B-cell lymphopenia An accelerated decline of specific Ab titers after initially normal primary Ab response & lower than normal secondary Ab response Clin Immunol 2008; 129:448-454
  • 87.  Antifungal prophylaxis: - In case of structural airway abnormalities - Mechanism; local epithelial impairment after recurrent bacterial pneumonia similar in cystic fibrosis or post-tuberculosis cavities - Prophylactic surgery
  • 88.  Omalizumab: - A – 32 –Y-old Thai female - NIH Scoring = 30 - Serum IgE > 2,000 iu/ml ( 10 pts) - Eosinophilia > 800 cell/ul ( 6 pts) - Severe eczema ( 4 pts) - Candidiasis of nails ( 2 pts) - Recurrent skin abscess ( 8) APJAI 2009; 27: 233-236
  • 89.  Omalizumab: - Firstly tried topical steroid & tacrolimus - Then, systemic steroid 30 mg/d, but flare up after dose tapering - Tried Omalizumab 300 mg SC q 2 wk, clinical improve after 1 month & gradually decreased systemic steroid APJAI 2009; 27: 233-236
  • 90. Causes of Death in HIES
  • 91. JACI 2007; 119: 1234-40
  • 92. JACI 2007; 119: 1234-40
  • 93. JACI 2007; 119: 1234-40
  • 94.
  • 95.   A rare primary immunodeficiency marked by abnormalities in the coordination of cell–cell signaling with the potential to affect TH17 cell, B cell, and neutrophil responses Clinical manifestations include recurrent skin and lung infections, serum IgE elevation, connective tissue repair and development alterations
  • 96.    STAT3 –HIES: - Pneumonia, pneumatocele, facial features, bone abnormalities DOCK 8 –HIES: - Viral skin infections, sepsis, neurological, malignancy, food allergy, decreased IgM Tyk 2-HIES: - Viral skin infections, sepsis, neurological
  • 97.   Investigations: - Eosinophilia - Hyper IgE - Decreased memory B cell - Decreased Th17 cell & IL-17 - Decreased T cell development Diagnosis - NIH scoring system - High-resolution PCR-based DNA-melting assays
  • 98.   Managements: - Supportive - ABT treatment - ABT & antifungal prophylaxis - Skin care - IVIG Causes of death: - Infection - Pulmonary hemorrhage

Editor's Notes

  1. 2 M: fever, I&amp;D , admit 3 d, ABT 7d2 Y : I&amp;D, ABT IV 4 Y : I&amp;D, ABT IV 7 Y : I&amp;D, ABT IV
  2. Eo &gt; 700 , aabnormal
  3. IgE 29600 , 5 Y
  4. Total IgE 296,000 IU/ml AT 5-y-old
  5. Primary teeth = 10
  6. Gene analysis not shown to be tested before, lost data
  7. Massive lt pleural effusion, patchy infiltration rthilar region
  8. Skin infection at scalp : bactroban bidTerramycin ointment bid at eyelids
  9. NB rash : scraping show Eo, other signs ; heat, erythema, tenderness not found. Improved by oral ABT &amp; dilute bleachHigh MB &amp; MR from aspergillosis &amp; gram neg ; Pseudomonas
  10. Arnold-Chiari I: cerebella tonsils protrudes in foramen magnum Fracture &amp; osteopenia found 50 %
  11. sIgE gradually reduced in adoles but clinical persists
  12. All need signal through STAT3
  13. IL-6: PROINFLAMMATORY cytokineIL-10: anti-inflammation cytokine
  14. HIES: Normal B cell number &amp; IgG, M, A level
  15. Physician score : &gt;= 15 likely, 10-14 indeterminate, &lt; 10 unlikely
  16. Bathing in bleach: 120 ml of bleach in tub of water 15 min* 3/wkAvoid parenchymal damage
  17. BMT : 2 CASES IN Germany, free of infection, viral skin for 2, 4 y
  18. Recommend : Oral ABT + IVIG BENEFIT in recurrent pulm infectionAlso antifungal needed in case with pneumatocele or bronchiectasis